PSA exam questions by type: What you’ll see and how long to spend on each

If you’re preparing for the Prescribing Safety Assessment (PSA), you’re not alone! Thousands of students will take it between October 2025 and June 2026. Knowing exactly what to expect on the day can make a huge difference to your confidence and performance.

In this post, we’ll take a deep dive into each PSA question type, how they’re structured, how many marks they carry, and roughly how long you should spend on each.

The PSA exam structure at a glance

The PSA is a two-hour, online assessment designed to test your prescribing competence. You’ll face 60 questions in total, divided across eight different sections, with a combined total of 200 marks.

We’ve included a simple table breakdown below: 

 

Question Type Number of Questions Marks per Question Total Marks
Prescribing (PWS) 8 10 80
Prescription Review (REV) 8 4 32
Planning Management (MAN) 8 2 16
Providing Information (COM) 6 2 12
Calculation Skills (CAL) 8 2 16
Adverse Drug Reactions (ADR) 8 2 16
Drug Monitoring (TDM) 8 2 16
Data Interpretation (DAT) 6 2 12

 

Total: 60 questions, 200 marks, 120 minutes.

Because the Prescribing section alone accounts for 40% of the total marks, managing your time effectively across each section is crucial!

PSA exam question types explained

Below, we’re taking a deep dive into what each question type involves, what it’s testing, and a suggested time allocation for each.

1. Prescribing (PWS) questions

8 questions | 10 marks each | 80 marks total

These are the heart of the PSA and the highest-scoring section. You’ll be asked to prescribe a drug based on a clinical scenario, using a digital prescription form.

Each prescription must be complete, including the drug name, dose, route, and frequency, and needs to be clinically appropriate for the patient’s condition, age, and comorbidities.

Top tip: Always check for contraindications, allergies, and interactions using the BNF (which you’ll have access to in some form during the exam).

Allotted time suggestion: Around 7 – 8 minutes per question (≈ 55 – 60 minutes total).

2. Prescription Review (REV) questions

8 questions | 4 marks each | 32 marks total

Here, you’ll review an existing prescription chart and identify any problems such as dosing errors, drug interactions, or missing information. You may need to choose what action to take or to correct an error.

Top tip: Be methodical, check each medication for indication, dose, route, and frequency before deciding what to change.

Allotted time suggestion: 3 – 4 minutes per question (≈ 28 – 30 minutes total).

3. Planning Management (MAN) questions

8 questions | 2 marks each | 16 marks total

You’ll be asked to choose the most appropriate next step in a patient’s management from several options, for example, which treatment to start, adjust, or stop.

Top tip: Read everything carefully; small details often change the correct answer.

Allotted time suggestion: 1.5 minutes per question (≈ 12 minutes total).

4. Providing Information (COM) questions 

6 questions | 2 marks each | 12 marks total

These test how you communicate with patients about their medicines. You might be asked what key advice to give when starting or stopping a treatment.

Top tip: Think about what a patient needs to know to use their medicine safely. Think, side effects, monitoring, and administration tips.

Allotted time suggestion: 1.5 minutes per question (≈ 9 minutes total).

5. Calculation Skills (CAL) questions

8 questions | 2 marks each | 16 marks total

You’ll calculate doses, infusion rates, or conversions. A simple calculator is provided in the exam interface, but many students find it faster to use their own.

Top tip: Double-check units and make sure your final answer makes clinical sense,  is it a realistic dose?

Allotted time suggestion: 2 minutes per question (≈ 16 minutes total).

6. Adverse Drug Reactions (ADR) questions

8 questions | 2 marks each | 16 marks total

You’ll interpret clinical scenarios to identify, manage, or prevent adverse drug reactions.

Questions might ask you to:

  • Identify which drug caused a patient’s new symptoms
  • Recognise a drug interaction
  • Decide on the best course of action after an adverse event

Top tip: Be ready to apply your pharmacology knowledge, and don’t forget to use the BNF interactions checker.

Allotted time suggestion: 1.5 – 2 minutes per question (≈ 12 – 16 minutes total).

7. Drug Monitoring (TDM) questions

8 questions | 2 marks each | 16 marks total

These assess how well you understand drug monitoring, knowing which tests to request, when to measure levels, and how to interpret results.

Top tip: Pay attention to trends in results (e.g. renal function) that might change drug safety or dosing.

Allotted time suggestion: 1.5 minutes per question (≈ 12 minutes total).

8. Data Interpretation (DAT) questions 

6 questions | 2 marks each | 12 marks total

You’ll analyse patient data such as lab results, drug levels, or vital signs (usually in the form of a graph or table) to make safe prescribing decisions.

Top tip: Look for patterns and remember, practice makes perfect! 

Allotted time suggestion: 1.5 minutes per question (≈ 9 minutes total).

Making the most of your 2 hours

Here’s how your time might look if you stick roughly to the suggested timings:

Section Time (approx.)
Prescribing 55 – 60 min
Prescription Review 25 – 30 min
All other sections combined 30 – 35 min
Total ≈120 min

 

Try to stay calm, mark for review, and move on if you’re stuck. Remember to leave a few minutes at the end to check the questions you’ve flagged. The prescribing section carries the most marks, but smaller sections can help boost your score if you answer efficiently.

Understanding the structure and weighting of PSA question types can transform how you prepare, helping you focus on high-yield sections, so plan your time wisely and walk into the exam with confidence.

For more guidance, explore the rest of our blogs on the Portal Post or our catalogue of free-to-use resources, including our 9 free eLearning resources specifically designed to support those sitting the PSA (PSA Prep).

Good luck, you’ve got this!

Learn about Yellow Card reporting with our new assessment

The Yellow Card scheme is the UK’s system for collecting and monitoring information about suspected side effects or safety concerns with medicines and medical devices. Run by the MHRA (Medicines and Healthcare products Regulatory Agency), it serves as a critical medicine surveillance tool.That’s exactly why we’ve developed a new training resource in partnership with the MHRA and the British Pharmacological Society (BPS).

When should you report?

Do you know what information to include? Whether your suspicion is strong enough to warrant a report? The MHRA recommends reporting every time on the basis of reasonable suspicion. You do not need to establish causation before submitting a report. A report should be made whenever you suspect a medicine may have caused an adverse reaction.

Building your knowledge with the new assessment

We’ve developed an MHRA Yellow Card scheme assessment specifically to help better understand the regulatory role of the MHRA, the importance of post-market surveillance activities in the real world and the value of reporting any suspected safety concerns to the Yellow Card scheme.

What the assessment covers:

The Assessment is a collaboration between BPS and the Medicines and Healthcare products Regulatory Agency (MHRA), and is delivered as a one-hour  formative assessment, containing two modules:

  1. Module 1: ‘MHRA and the Yellow Card scheme’ – general knowledge questions about the role of the MHRA and the Yellow Card scheme; and
  2. Module 2: ‘Reporting Adverse Incidents’ – scenario-based case studies about adverse incidents and reporting routes.

Why complete it now:

Learning about Yellow Card reporting during training means it becomes integrated into your practice from day one. When you encounter your first suspected adverse drug reaction, you’ll already know the appropriate steps. The process will be familiar rather than something you need to investigate while managing clinical responsibilities.

Pharmacovigilance also features in professional assessments, including the PSA. Understanding how to identify and report safety concerns is a core competency expected of newly qualified prescribers.

How it works:

The assessment is available on the portal and can be completed at a time that suits your schedule. You’ll work through interactive case based scenarios that mirror real clinical situations. Once completed, you’ll be ready to use the Yellow Card scheme throughout your career via the online portal at yellowcard.mhra.gov.uk or the Yellow Card app.

Ready to get started?

Access the MHRA Yellow Card scheme assessment through the portal’s eLearning section  https://portal.bpsassessment.com/product/yellow-card-scheme/ 

Explore more learning resources

The Yellow Card assessment is part of our comprehensive range of training materials designed to support your prescribing journey, more resources can be found here: https://portal.bpsassessment.com/ 

For more information about the Yellow Card scheme visit: 

https://yellowcard.mhra.gov.uk/ 

https://www.bps.ac.uk/education-engagement/society-training-opportunities/bps-assessment-training-solutions/mhra-yellow-card-scheme-assessment